These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4110779)

  • 1. [Fibrinogen and fibrin split products and their biological importance].
    Krantz S; Fiedler H; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):1-13. PubMed ID: 4110779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modern concepts of the hemostatic and fibrinolytic systems].
    Andreenko GV
    Klin Med (Mosk); 1974 Apr; 52(4):13-23. PubMed ID: 4282102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinogen and fibrin in the process of blood clotting and fibrinolysis].
    Kowrygo W
    Wiad Lek; 1978 Jun; 31(12):845-48. PubMed ID: 358611
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutual interaction between platelets and fibrinogen and its derivatives.
    Stachurska J; Wegrzynowicz Z; Latallo ZS; Kopec M
    Acta Univ Carol Med Monogr; 1972; 53():17-20. PubMed ID: 4275439
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation, oestrogen and the menopause.
    Notelovitz M
    Clin Obstet Gynaecol; 1977 Apr; 4(1):107-28. PubMed ID: 140032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and fibrin: biochemistry and pathophysiology.
    Budzynski AZ
    Crit Rev Oncol Hematol; 1986; 6(2):97-146. PubMed ID: 2878736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen. Hereditary hypo--and dysfibrinogenemia].
    Gajdos A
    Nouv Presse Med; 1973 Apr; 2(16):1067-71. PubMed ID: 4267566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular mechanisms of blood coagulation and fibrinolysis activation].
    Worowski K
    Postepy Hig Med Dosw; 1980; 34(3):189-233. PubMed ID: 6455654
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the physiological roles of fibrinogen and fibrin].
    Copley AL
    Postepy Biochem; 1968; 14(3):343-8. PubMed ID: 4879746
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin I effect of fibrin].
    Dolesobel W
    Wien Med Wochenschr; 1972 Oct; 122(41):585-90. PubMed ID: 4628353
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical aspects and therapy of disseminated intravascular coagulation].
    Lasch HG
    Hamatol Bluttransfus; 1970; 9():121-31. PubMed ID: 5508064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of fibrinolysis (review of the literature)].
    Kovalenko AN
    Vrach Delo; 1983 Jan; (1):10-5. PubMed ID: 6223445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic activity of a protease isolated from Aspergillus ochraceus].
    Klöcking HP; Markwardt F
    Acta Biol Med Ger; 1971; 26(1):35-44. PubMed ID: 5103710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Technics for the study of the blood coagulation and fibrinolytic system].
    Lasch HG; Heene D
    Internist (Berl); 1968 Feb; 9(2):42-8. PubMed ID: 4234941
    [No Abstract]   [Full Text] [Related]  

  • 16. INfluence of Pseudomonas aeruginosa proteases on prothrombin, plasminogen and fibrinogen.
    Pulverer G; Wegrzynowicz Z; Ko HL; Jeljaszewicz J
    Zentralbl Bakteriol A; 1980; 248(1):99-109. PubMed ID: 6781167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinogen and its break-down products].
    Gormsen J; Feddersen C
    Ugeskr Laeger; 1973 Aug; 135(32):1678-82. PubMed ID: 4272617
    [No Abstract]   [Full Text] [Related]  

  • 18. A case report of a paroxysmal nocturnal hemoglobinuria with increased coagulation activation markers while on treatment with LMWH with anti-Xa levels above the therapeutic range.
    Arkel YS; Ku DH; Lake C; Lam X; Spielvogel A
    Thromb Haemost; 2000 Feb; 83(2):348-9. PubMed ID: 10739398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Disseminated intravascular coagulation].
    Amir J
    Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
    [No Abstract]   [Full Text] [Related]  

  • 20. Theories of blood coagulation. Properties and interactions of blood clotting factors.
    Kazal LA
    Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.